Alzheimer Disease & Associated Disorders

Papers
(The median citation count of Alzheimer Disease & Associated Disorders is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Sex-related Differences in Tau Positron Emission Tomography (PET) and the Effects of Hormone Therapy (HT)26
Expanded Demographic Norms for Version 3 of the Alzheimer Disease Centers’ Neuropsychological Test Battery in the Uniform Data Set24
Vascular Dementia, Depression, and Financial Capacity Assessment23
Unraveling Ariadne’s Thread Into the Labyrinth of aMCI20
The Utility of the National Alzheimer’s Coordinating Center’s Database for the Rapid Assessment of Evolving Neuropathologic Conditions19
The Insular Cortex, Alzheimer Disease Pathology, and Their Effects on Blood Pressure Variability18
Alpha-synuclein Levels in the Differential Diagnosis of Lewy Bodies Dementia and Other Neurodegenerative Disorders15
Mild Alzheimer Disease, Financial Capacity, and the Role of Depression15
Physical Exercise and Longitudinal Trajectories in Alzheimer Disease Biomarkers and Cognitive Functioning13
Effects of Noninvasive Brain Stimulation (NIBS) on Cognitive Impairment in Mild Cognitive Impairment and Alzheimer Disease12
Sociodemographic and Clinical Characteristics of 1350 Patients With Young Onset Dementia12
Physical Performance and Cognition in a Diverse Cohort11
Neural Basis of Long-term Musical Memory in Cognitively Impaired Older Persons11
Racial/Ethnic Disparities in Young Adulthood and Midlife Cardiovascular Risk Factors and Late-life Cognitive Domains10
The Measurement of Everyday Cognition (ECog)10
Dementia Incidence in the Elderly Population of Greece9
Bone Mineral Density Measurements and Association With Brain Structure and Cognitive Function9
Patient and Relative Experiences and Decision-making About Genetic Testing and Counseling for Familial ALS and FTD9
Predictors of Willingness to Enroll in Hypothetical Alzheimer Disease Biomarker Studies that Disclose Personal Results8
Androgen Deprivation Therapy Use and Risk of Mild Cognitive Impairment in Prostate Cancer Patients8
Prevalence of Mild Cognitive Impairment in the Lothian Birth Cohort 19368
Association Between Cognitive Test Performance and Subjective Cognitive Decline in a Diverse Cohort of Older Adults8
Confluent White Matter in Progression to Alzheimer Dementia8
Biomarker Use for Dementia With Lewy Body Diagnosis7
Clinical Care and Unmet Needs of Individuals With Dementia With Lewy Bodies and Caregivers7
Value of a Panel of 6 Serum Biomarkers to Differentiate Between Healthy Controls and Mild Cognitive Impairment Due to Alzheimer Disease7
An Initial Empirical Operationalization of the Earliest Stages of the Alzheimer’s Continuum7
Cardiac and Blood Pressure Safety of Transdermal Rivastigmine in Elderly Patients With Dementia With Lewy Bodies7
Efficacy of Mealtime Interventions for Malnutrition and Oral Intake in Persons With Dementia7
Cognitive Behavioral Therapy for Mood and Insomnia in Persons With Dementia7
Assessment of Functional Near-infrared Spectroscopy by Comparing Prefrontal Cortex Activity6
Do the Benefits of Educational Attainment for Late-life Cognition Differ by Racial/Ethnic Group?6
Validity of the Mini-Mental State Examination-2 in Diagnosing Mild Cognitive Impairment and Dementia in Patients Visiting an Outpatient Clinic in the Netherlands6
Staging of Dementia Severity With the Hong Kong Version of the Montreal Cognitive Assessment (HK-MoCA)’s6
Functional Decline and Body Composition Change in Older Adults With Alzheimer Disease6
Beliefs, Understanding, and Barriers Related to Dementia Research Participation Among Older African Americans6
Genetic Variants Associated With Alzheimer Disease in the 22 Arab Countries6
The Association Between Patterns of Social Engagement and Conversion From Mild Cognitive Impairment to Dementia6
Intravesical BCG and Incidence of Alzheimer Disease in Patients With Bladder Cancer6
Social Inequalities in Life Expectancy and Mortality in People With Dementia in the United Kingdom5
Clinical Profiles of Arteriolosclerosis and Alzheimer Disease at Mild Cognitive Impairment and Mild Dementia in a National Neuropathology Cohort5
Cerebral Amyloid Angiopathy-related Inflammation Presenting With a Cystic Lesion in Young-onset Alzheimer Disease5
Association of Dementia and Vascular Risk Scores With Cortical Thickness and Cognition in Low-risk Middle-aged Adults5
Perceptions of Research Burden and Retention Among Participants in ADRC Cohorts5
Exercise and the Risk of Mild Cognitive Impairment5
Outcome Measures for Dementia With Lewy Body Clinical Trials5
Comparison of the Accuracy of Short Cognitive Screens Among Adults With Cognitive Complaints in Turkey5
Long-term Neuropsychiatric Complications and 18F-FDG-PET Hypometabolism in the Brain From Prolonged Infection of COVID-195
Novel PSEN1 and PSEN2 Mutations Identified in Sporadic Early-onset Alzheimer Disease and Posterior Cortical Atrophy4
Physical and Vestibular Physical Therapy Referrals in People With Alzheimer Disease4
Evaluation of the Clinical Features Accompanied by the Gene Mutations4
Association Between GlycA and Cognitive Function4
“My Parent’s Body Is Sacred”4
Predicting Mental Decline Rates in Mild Cognitive Impairment From Baseline MRI Volumetric Data4
Right Temporal Lobe Variant of Frontotemporal Dementia4
Meta-analysis of the Connection Between Alzheimer Disease and Telomeres4
Genetic Variants and Haplotypes of TOMM40, APOE, and APOC1 are Related to the Age of Onset of Late-onset Alzheimer Disease in a Colombian Population4
Early Impairment in the Ventral Visual Pathway Can Predict Conversion to Dementia in Patients With Amyloid-negative Amnestic Mild Cognitive Impairment4
Phase 1 Single Ascending and Multiple Ascending Dose Studies of Phosphodiesterase-9 Inhibitor E20274
Obesity and Oxidative Stress in Older Adults At Risk for Dementia4
Evolving Causes of Rapidly Progressive Dementia4
Impact of Disturbed Rest-activity Rhythms on Activities of Daily Living in Moderate and Severe Dementia Patients4
Subtle Changes in Medication-taking Are Associated With Incident Mild Cognitive Impairment4
Examining the Role of Aging Perceptions in Subjective Cognitive Decline3
Apolipoprotein E4 Moderates the Association Between Vascular Risk Factors and Brain Pathology3
Temporal Speech Parameters Indicate Early Cognitive Decline in Elderly Patients With Type 2 Diabetes Mellitus3
Psychological Impact of Predictive Genetic Testing for Inherited Alzheimer Disease and Frontotemporal Dementia3
Factor Consistency of Neuropsychological Test Battery Versions in the NACC Uniform Data Set3
β-Amyloid Orchestrates Factor XII and Platelet Activation Leading to Endothelial Dysfunction and Abnormal Fibrinolysis in Alzheimer Disease3
Association Between Adherence to the MIND Diet and Cognitive Performance is Affected by Income3
Takotsubo Cardiomyopathy in an Alzheimer Disease Patient3
Familiarity in Mild Cognitive Impairment as a Function of Patients’ Clinical Outcome 4 Years Later3
Using Direct-to-Consumer Genetic Testing Results to Accelerate Alzheimer Disease Clinical Trial Recruitment3
Engaging Diverse Older Adults With Cognitive Impairment and Caregivers in Advance Care Planning3
Effects of Depression on Changes in Cognitive Function in Older Adults3
Tailoring Research Recruitment for Acute Care Settings3
Novel Presenilin-1 Mutation (Ala275Ser) Associated With Clinical Features of Dementia With Lewy Bodies3
Carotid Intima-Media Thickness (cIMT) and Cognitive Performance3
Interactions Between Acute Infarcts and Cerebrovascular Pathology Predict Poststroke Dementia3
Alzheimer Disease Worries, Fears, and Stigma and Their Relationship to Genetic and Interventional Research Engagement3
Limbic-predominant Age-related TDP-43 Encephalopathy and Distinct Longitudinal Profiles of Domain-specific Literacy3
Brain 18F-Florbetapir PET/CT Findings in an Early-onset Alzheimer Disease Patient Carrying Presenilin-1 G378E Mutation3
Polymorphism in the MAGI2 Gene Modifies the Effect of Amyloid β on Neurodegeneration3
Postsecondary Education and Late-life Cognitive Outcomes Among Black and White Participants in the Project Talent Aging Study3
Neck Circumference and Cerebral Gray Matter Volume3
Limited Longitudinal Change in Self-reported Spatial Navigation Ability in Preclinical Alzheimer Disease3
Role of Apolipoprotein E in the Clinical Profile of Atypical Parkinsonian Syndromes3
Research Priorities of Individuals and Caregivers With Lewy Body Dementia2
Screening for Dementia and Cognitive Decline in Adults With Down Syndrome2
The Association Between Cancer and Spousal Rate of Memory Decline2
Psychometric Properties of the ICECAP-O Quality of Life Measurement Tool When Self-reported by Community-dwelling Older People With Mild and Moderate Dementia2
Decreased Expression of Cerebral Dopamine Neurotrophic Factor in Platelets of Probable Alzheimer Patients2
Comparison of Amyloid in Cerebrospinal Fluid, Brain Imaging, and Autopsy in a Case of Progressive Supranuclear Palsy2
An Agitated Patient With COVID-19 Infection and Early-onset Alzheimer Disease2
West Nile Virus Neuroinvasive Disease Accelerating Probable Dementia With Lewy Bodies2
Brachial Flow-mediated Dilation and Risk of Dementia2
Alzheimer’s Disease Neuropathologic Change and Vitamin Supplement Use Decades Earlier2
Validation of the Short Version of the 10/66 Dementia Diagnosis in Urdu in Karachi, Pakistan2
Predictors of Dementia in the Oldest Old2
A Model to Assess the Outcomes Associated With Dementia With Lewy Bodies2
Association of Being Accompanied at Medical Consultation and Having Memory Complaints With Cognitive Impairment in Elderly Brazilian Outpatients2
Impact of COVID-19 Pandemic on Research Participation Among Older African Americans2
Impaired Color Discrimination in Alzheimer Disease Dementia2
Driving Habits of Older Adults2
GAD65 Autoimmune Encephalitis2
A National Assessment of Alzheimer Disease and Antipsychotic Medication Prescribing Among Older Adults in Ambulatory Care Settings2
Direct Mail Recruitment to a Potential Participant Registry2
Gray Matter Volume as Evidence for Cognitive Reserve in Bilinguals With Mild Cognitive Impairment2
Factors Associated With Sleep Quality in Hospitalized Persons With Dementia2
Pure Prosodic Type of Primary Progressive Apraxia of Speech Mimicking Nonfluent Aphasia and Later Progressing to Corticobasal Syndrome2
Comparing Performance of Different Predictive Models in Estimating Disease Progression in Alzheimer Disease1
Increasing the Cognitive Screening Efficiency of Global Phase III Trials in Early Alzheimer Disease1
In Individuals With Subjective Cognitive Decline, Age, Memory and Speed Scores at Baseline Predict Progression to Cognitive Impairment1
A Comparison of Methods for Predicting Future Cognitive Status1
Assessing Social Cognition in Older Adults1
Atypical Young-onset Dementia in Cerebral Thromboangiitis Obliterans1
Development and Validation of a Multidimensional Short Version Zarit Burden Interview (ZBI-9) for Caregivers of Persons With Cognitive Impairment1
Dyadic Enrollment in a Phase 3 Mild Cognitive Impairment Clinical Trial1
Changes in Polypharmacy and Psychotropic Medication Use After Diagnosis of Major Neurocognitive Disorders1
Alzheimer Disease: A New Beginning in Therapeutics1
Odor Identification Testing Can Assist in the Clinical Distinction Between Psychiatric Disorders and Neurological/Neurodegenerative Disorders1
Musical Bridges to Memory1
Everyday Abilities Scale for India in Screening for Poststroke Dementia Among Young Stroke Survivors1
Caring for the Caregivers1
Healthy Lifestyle Behaviors and Viewpoints Among Members of an Alzheimer Prevention Registry1
Effect of Neurotoxin Exposure on Blood Biomarkers of Neurodegeneration and Alzheimer Disease1
A National Assessment of Alzheimer Disease and Antipsychotic Medication Prescribing Among Older Adults in Ambulatory Care Settings1
A New and Tidier Setting1
The Impact of Amyloid PET Disclosure on Quality of Life in Patients With Young Onset Dementia1
Early-onset Alzheimer Disease Associated With Neuromyelitis Optica Spectrum Disorder1
Adapting Alzheimer Disease and Related Dementias Clinical Research Evaluations in the Age of COVID-191
Predictors of Cognitive Change in Parkinson Disease1
Identifying Adaptive and Maladaptive Behaviors Following a Diagnosis of Mild Cognitive Impairment1
Remuneration and Recruitment of Study Participants for AD Cohort Studies From the General Public and From Minority Communities1
Utility of the Repeat and Point Test for Subtyping Patients With Primary Progressive Aphasia1
Impaired Emotion Recognition: A Potential Marker for Social Behavioral Problems in Patients With Amnestic Mild Cognitive Impairment and Early Alzheimer Disease?1
Economic Burden of Chronic Comorbidities Among Community-Dwelling Older Adults With Dementia1
MoCA Intraindividual Cognitive Variability in Older Adults With Type 1 Diabetes1
Development of a Comprehensive Battery to Collect Social and Structural Determinants of Health (SSDOH) in Cognitively Normal or Very Mildly Impaired Persons1
Education as a Moderator of Help Seeking Behavior in Subjective Cognitive Decline1
Providing a Purposeful and Stimulating Volunteer Opportunity for Older Adults With Mild Cognitive Impairment1
Computer-based Eye-tracking Analysis of King-Devick Test Differentiates Persons With Idiopathic Normal Pressure Hydrocephalus From Cognitively Unimpaired1
The Impact of Episodes of Lucidity on People Living With Dementia and Their Caregivers1
Does a Cancer Diagnosis in Mid-to-Later Life Modify Racial Disparities in Memory Aging?1
0.017297983169556